Markers of early vascular ageing

Current Pharmaceutical Design

Volumn 23, Issue 22, 2017, Pages 3200-3204

  Kotsis, Vasilios ^a   Antza, Christina ^a   Doundoulakis, Ioannis ^a   Stabouli, Stella ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Arterial stiffness; Cardiovascular disease; Early arteriosclerosis; Early atherosclerosis; Early vascular aging; Intima media thickness

Indexed keywords

AUTACOID; BIOLOGICAL MARKER;

AGE; AGING; ATHEROSCLEROSIS; BLOOD; CARDIOVASCULAR DISEASE; HUMAN; PATHOLOGY;

AGE FACTORS; AGING; ATHEROSCLEROSIS; BIOMARKERS; CARDIOVASCULAR DISEASES; HUMANS; INFLAMMATION MEDIATORS;

EID: 85034853587     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/1381612823666170328142433     Document Type: Review

References (32)

1. Kotsis V, Stabouli S, Pitiriga V, Toumanidis S, Papamichael C, Zakopoulos N. Ambulatory blood pressure monitoring and target organ damage: effects of age and sex. Blood Pres Monitor 2006; 11(1): 9-15.
2. Levine ME. Modeling the rate of senescence: can estimated biological age predict mortality more accurately than chronological age? J Gerontol Series A, Biol Sci Med Sci 2013; 68(6): 667-74.
3. Klemera P, Doubal S. A new approach to the concept and computa-tion of biological age. Mechanisms Ageing develop 2006; 127(3): 240-8.
4. Belsky DW, Caspi A, Houts R, et al. Quantification of biological aging in young adults. Proc Natl Acad Sci USA 2015; 112(30): E4104-10.
5. Shah T, Casas JP, Cooper JA, et al. Critical appraisal of CRP meas-urement for the prediction of coronary heart disease events: new data and systematic review of 31 prospective cohorts. Int J Epide-miol 2009; 38(1): 217-31.
6. Kaptoge S, Di Angelantonio E, Pennells L, et al. C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med 2012; 367(14): 1310-20.
7. Sabater-Lleal M, Huang J, Chasman D, et al. Multiethnic meta-analysis of genome-wide association studies in >100 000 subjects identifies 23 fibrinogen-associated Loci but no strong evidence of a causal association between circulating fibrinogen and cardiovascular disease. Circulation 2013; 128(12): 1310-24.
8. Blankenberg S, Zeller T, Saarela O, et al. Contribution of 30 bio-markers to 10-year cardiovascular risk estimation in 2 population cohorts: the MONICA, risk, genetics, archiving, and monograph (MORGAM) biomarker project. Circulation 2010; 121(22): 2388-97.
9. Melander O, Newton-Cheh C, Almgren P, et al. Novel and conven-tional biomarkers for prediction of incident cardiovascular events in the community. JAMA 2009; 302(1): 49-57.
10. Kim HC, Greenland P, Rossouw JE, et al. Multimarker prediction of coronary heart disease risk: the Women's Health Initiative. J Am College Cardiol 2010; 55(19): 2080-91.
11. Wang TJ, Gona P, Larson MG, et al. Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med 2006; 355(25): 2631-9.
12. Folsom AR, Chambless LE, Ballantyne CM, et al. An assessment of incremental coronary risk prediction using C-reactive protein and other novel risk markers: the atherosclerosis risk in communities study. Arch Intern Med 2006; 166(13): 1368-73.
13. Wang TJ, Wollert KC, Larson MG, et al. Prognostic utility of novel biomarkers of cardiovascular stress: the Framingham Heart Study. Circulation 2012; 126(13): 1596-604.
14. Zethelius B, Berglund L, Sundstrom J, et al. Use of multiple bio-markers to improve the prediction of death from cardiovascular causes. N Engl J Med 2008; 358(20): 2107-16.
15. Aalto K, Maksimow M, Juonala M, et al. Soluble vascular adhesion protein-1 correlates with cardiovascular risk factors and early athe-rosclerotic manifestations. Arterioscler Thromb Vasc Biol 2012; 32(2): 523-32.
16. Brouilette SW, Moore JS, McMahon AD, et al. Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case-control study. Lancet 2007; 369(9556): 107-14.
17. McKenna M, Wolfson S, Kuller L. The ratio of ankle and arm arterial pressure as an independent predictor of mortality. Atherosclerosis 1991; 87(2-3): 119-28.
18. Heald CL, Fowkes FG, Murray GD, Price JF. Risk of mortality and cardiovascular disease associated with the ankle-brachial index: Systematic review. Atherosclerosis 2006; 189(1): 61-9.
19. Fowkes FG, Murray GD, Butcher I, et al. Development and valida-tion of an ankle brachial index risk model for the prediction of cardiovascular events. Eur J Preventive Cardiol 2014; 21(3): 310-20.
20. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK, Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardio-vascular Health Study Collaborative Research Group. N Engl J Med 1999; 340(1): 14-22.
21. Kotsis VT, Pitiriga V, Stabouli SV, et al. Carotid artery intima-media thickness could predict the presence of coronary artery le-sions. Am J Hypertens 2005; 18(5 Pt 1): 601-6.
22. Nambi V, Chambless L, He M, et al. Common carotid artery in-tima-media thickness is as good as carotid intima-media thickness of all carotid artery segments in improving prediction of coronary heart disease risk in the Atherosclerosis Risk in Communities (ARIC) study. Eur Heart J 2012; 33(2): 183-90.
23. Kotsis V, Stabouli S, Pitiriga V, Papamichael C, Toumanidis S, Zakopoulos N. Impact of gender on 24-h ambulatory blood pressure and target organ damage. J Human Hypertens 2006; 20(9): 658-65.
24. Yeboah J, Crouse JR, Hsu FC, Burke GL, Herrington DM. Brachial flow-mediated dilation predicts incident cardiovascular events in older adults: the Cardiovascular Health Study. Circulation 2007; 115(18): 2390-7.
25. Yeboah J, Folsom AR, Burke GL, et al. Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a popu-lation-based study: the multi-ethnic study of atherosclerosis. Circulation 2009; 120(6): 502-9.
26. Vliegenthart R, Oudkerk M, Song B, van der Kuip DA, Hofman A, Witteman JC. Coronary calcification detected by electron-beam computed tomography and myocardial infarction. The Rotterdam Coronary Calcification Study. Eur Heart J 2002; 23(20): 1596-603.
27. Criqui MH, Denenberg JO, Ix JH, et al. Calcium density of coronary artery plaque and risk of incident cardiovascular events. JAMA 2014; 311(3): 271-8.
28. Jordan J, Nilsson PM, Kotsis V, et al. Joint scientific statement of the European Association for the Study of Obesity and the European Society of Hypertension: Obesity and early vascular ageing. J Hypertens 2015; 33(3): 425-34.
29. Nilsson PM, Boutouyrie P, Cunha P, et al. Early vascular ageing in translation: from laboratory investigations to clinical applications in cardiovascular prevention. J Hypertens 2013; 31(8): 1517-26.
30. Kotsis V, Stabouli S, Karafillis I, et al. Arterial stiffness and 24 h ambulatory blood pressure monitoring in young healthy volunteers: the early vascular ageing Aristotle University Thessaloniki Study (EVA-ARIS Study). Atherosclerosis 2011; 219(1): 194-9.
31. Papakatsika S, Stabouli S, Antza C, Kotsis V. Early vascular aging: A new target for hypertension treatment. Curr Pharm Des 2016; 22(1): 122-6.
32. Mattace-Raso FU, van der Cammen TJ, Hofman A, et al. Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. Circulation 2006; 113(5): 657-63.